rs3827478
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001122606.1(LAMP2):āc.1143A>Gā(p.Ala381Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00576 in 1,197,967 control chromosomes in the GnomAD database, including 126 homozygotes. There are 2,297 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001122606.1 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMP2 | NM_002294.3 | c.*2746A>G | 3_prime_UTR_variant | 9/9 | ENST00000200639.9 | NP_002285.1 | ||
LAMP2 | NM_001122606.1 | c.1143A>G | p.Ala381Ala | synonymous_variant | 9/9 | NP_001116078.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMP2 | ENST00000434600.6 | c.1143A>G | p.Ala381Ala | synonymous_variant | 9/9 | 1 | ENSP00000408411.2 | |||
LAMP2 | ENST00000200639 | c.*2746A>G | 3_prime_UTR_variant | 9/9 | 1 | NM_002294.3 | ENSP00000200639.4 |
Frequencies
GnomAD3 genomes AF: 0.0143 AC: 1595AN: 111836Hom.: 19 Cov.: 23 AF XY: 0.0144 AC XY: 490AN XY: 34070
GnomAD3 exomes AF: 0.0102 AC: 1644AN: 161044Hom.: 36 AF XY: 0.00812 AC XY: 413AN XY: 50868
GnomAD4 exome AF: 0.00488 AC: 5301AN: 1086077Hom.: 107 Cov.: 28 AF XY: 0.00511 AC XY: 1807AN XY: 353869
GnomAD4 genome AF: 0.0143 AC: 1598AN: 111890Hom.: 19 Cov.: 23 AF XY: 0.0144 AC XY: 490AN XY: 34134
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 30, 2011 | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Danon disease Benign:2
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 22, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Hypertrophic cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at